8p11-12-amplified breast and lung cancer were highly sensitive to FGFR1 and PI3K inhibitors, and this effect was abolished in 4EBP1 CRISPR-cas9 knockout cells. This evidence concerns the gene FGFR1 and lung carcinoma.